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Abstract: Homer1a is upregulated by several different 
antidepressant measures, including non-pharmacologi-
cal treatments, like sleep deprivation (SD) and electrocon-
vulsive therapy (ECT) and antidepressant drugs, such as 
imipramine, fluoxetine and ketamine. Homer1a induction 
might thus be a crucial joint mechanism for antidepres-
sant therapy in general. However, the upstream signaling 
pathways that regulate or induce Homer1a expression are 
still not well understood. The main focus of the present 
review is to offer an overview of the current knowledge 
about the potential role of Homer1a in depression and the 
signaling pathways responsible for Homer1a regulation. It 
is suggested here that a detailed characterization of the 
signaling mechanisms leading to Homer1a expression 
might provide novel therapeutic targets for antidepres-
sant drug development.
Keywords: adenosine A1 receptor; BDNF; depression; ERK 
pathway; Homer1a; Ras.
Introduction
Major depressive disorder is one of the most prevalent 
forms of mental illness. It is a complex and heterogeneous 
disorder, which imposes a severe economic burden on 
society (Krishnan and Nestler 2010). Most of the available 
antidepressant drugs require weeks or months to relieve 
the symptoms, they have low response and remittance 
rates and cause various side effects. The limited efficacy 
of the current antidepressants underlines the need to 
look for novel fast-acting and effective antidepressant 
measures. Treatment with a low dose of ketamine and 
non-pharmacological interventions, such as sleep depri-
vation (SD) and electroconvulsive therapy (ECT) emerged 
as rapid and effective antidepressant therapies, though 
their mechanism of action is not well understood (Berman 
et  al., 2000; Kato, 2009; Benedetti and Colombo, 2011). 
A solid knowledge of the mechanism of action and the 
neurobiological effects of the current antidepressant ther-
apies would facilitate the development of new antidepres-
sant drugs.
Recently, we proposed that the induction of Homer1a, 
a neuronal immediate-early gene involved in the regula-
tion of synaptic plasticity, is a common mechanism of 
action of several antidepressant treatments (Serchov et al., 
2015a). The main focus of the present review is to offer an 
overview of the current knowledge about the relationship 
that Homer1a has with depression and with antidepres-
sant therapy and the signaling pathways responsible for 
Homer1a regulation.
Homer1 proteins
The Homer family consists of three independent mamma-
lian genes (Brakeman et al., 1997; Kato et al., 1998), each 
with several splice variants including the long isoform 
Homer1b/c and the short isoform Homer1a, which are the 
most studied among them (Bottai et al., 2002; Klugmann 
et al., 2005). The long Homer isoforms are constitutively 
expressed, while the expression of Homer1a is relatively 
low under normal conditions and similar to other imme-
diate early genes (IEG) increases rapidly to neuronal 
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activity (Brakeman et  al., 1997). In contrast to BDNF, 
another complex IEG, which uses different promoters to 
switch from constitutive to activity-dependent expression 
(Timmusk et  al., 1993), a different mechanism operates 
for Homer1. Homer1b/c and Homer1a are derived by alter-
native splicing of a common primary transcript adapting 
a constitutively expressed gene to function also as IEG. 
Homer1 gene contains promoter-distal and promoter-
proximal functional poly(A) sites at the end of the exons 
corresponding, respectively to Homer1b/c and Homer1a 
(Bottai et  al., 2002). Homer1a results from switching of 
the transcriptional termination from promoter-distal to 
promoter-proximal poly(A) site within the central intron 5. 
This process is enhanced by extracellular stimuli and it 
is independent from Homer1 promoter (Niibori et  al., 
2006). Unlike most IEGs that encode transcription factors, 
Homer1a is unique, because it functions directly at the 
synapses.
All Homer isoforms are characterized by a conserved 
N-terminal EVH1 ligand-binding domain, that interacts 
with many components of the postsynaptic density (PSD) 
(Brakeman et al., 1997; Kato et al., 1998; Xiao et al., 1998; 
Tu et  al., 1998, 1999; Beneken et  al., 2000; Feng et  al., 
2002; Hwang et al., 2003; Yuan et al., 2003). In addition 
to EVH1 domain, all long Homer isoforms, including 
Homer1b/c, exhibit a C-terminal coiled-coil (CC) domain, 
which mediates self-association and multimerization. 
Thus, via CC domain the constitutively expressed long 
Homer proteins act as scaffolding molecules that form 
a polymeric network structure at the PSD and facilitate 
clustering of specific synaptic proteins, modulating their 
activities at neuronal synapses (Xiao et al., 1998; Tu et al., 
1988, 1999; Xiao et al., 2000; Hayashi et al., 2006, 2009). 
In addition to its role as an adaptor protein, it has been 
shown that Homer functions as ligand and directly modu-
lates the Ca2+ release gain via ryanodine receptor (Feng 
et  al., 2002). The long Homer1b/c links metabotropic 
glutamate receptors (mGluR1 and mGluR5) with NMDA 
receptors (Perroy et  al., 2008; Bertaso et  al., 2010) and 
many proteins involved in Ca2+ signaling (Tu et al., 1998; 
Feng et al., 2002; Hwang et al., 2003; Yuan et al., 2003), 
all of which have been implicated in the pathophysiology 
of mood disorders (Galeotti et al., 2008a,b; Krystal et al., 
2010; Miller et al., 2014; Newell and Matosin, 2014). There-
fore, abnormal clustering and declustering of Homer1b/c 
may provide an important mechanism that underlies the 
pathophysiological processes of depression (Szumlinski 
et al., 2006; Luo et al., 2012).
The short Homer1a lacks the CC domain and there-
fore does not form dimers with other Homer proteins 
 (Brakeman et  al., 1997; Kato et  al., 1998). Instead it 
interferes with the scaffolding capability of long Homers 
by competitively binding the target proteins of Homer1b/c 
(Kammermeier and Worley, 2007). In general, Homer1a 
appears to be an important regulator of the activity-
induced remodeling of synaptic structures (Inoue et  al., 
2007). Indeed, it has been identified as a member of the 
so-called plasticity-related proteins that promote persis-
tent late phase synaptic plasticity (Okada et  al., 2009). 
Thus, Homer1a provides flexible adaptation to environ-
mental demands and as much as clinical depression can 
be seen as a result of failed adaptation to stress, Homer1a 
up- regulation might evoke its antidepressant effects by 
improving synaptic reorganization in neural networks 
salient for mood regulation.
Homer1a in depression and anti­
depressant treatments
The potential involvement of Homer1a in depression-like 
behavior has been suggested in several reports (Lominac 
et  al., 2005; Szumlinski et  al., 2005, 2006; Kato, 2009; 
Rietschel et  al., 2010; Sun et  al., 2011). Collectively, the 
data on Homer1 suggest distinct roles for both isoforms: 
Homer1a and Homer1b/c in behavioral response to 
stress. General deletion of Homer1 enhances anxiety- and 
depression-like behavior in mice (Szumlinski et al., 2005). 
Homer1 knockout (KO) mice have elevated plasma levels 
of corticosterone and aldosterone (Grinevich et al., 2011), 
suggesting that Homer1 is involved in the regulation of 
hypothalamic-pituitary-adrenal axis activity (Grinevich 
et al., 2012). The amplified behavioral response to stress-
ors in Homer1KO mice appears to result from an inability 
to induce an increase of Homer1a in the medial prefrontal 
cortex (mPFC), because adeno-associated virus-mediated 
restoration of Homer1a in the mPFC of KO mice relieves the 
depression-like behavior (Lominac et al., 2005). In contrast, 
restoration of Homer1b/c in mPFC of Homer1KO mice even 
enhance genotypic differences (Lominac et al., 2005), con-
sistent with anxiogenic effects observed by hippocampal 
overexpression of Homer1g, a Homer1 isoform possessing 
only CC domain (Klugmann et al., 2005). Thus, an induc-
tion of Homer1a within cortical structures facilitates the 
ability to cope with stressors, whereas the overexpression 
of the CC-Homer1 isoforms leads to behavioral debilitation 
(Szumlinski et  al., 2006). In support of this proposition, 
we demonstrated that mice subjected to model of chronic 
depression (CDM) show reduced Homer1a expression in 
the mPFC, whereas treatment with several antidepres-
sant measures, including chronic treatment with classical 
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antidepressants, like imipramine and fluoxetine, as well 
as acute ketamine treatment or 6 h of SD strongly increase 
Homer1a levels in this region (Serchov et al., 2015a). Inter-
estingly, specific siRNA knockdown of Homer1a in mPFC 
enhances depressive-like behavior and prevented the anti-
depressant effects of SD, imipramine and ketamine treat-
ment, while viral overexpression of Homer1a in this region 
promotes antidepressant effects, demonstrating that 
Homer1a expression specifically in the mPFC is inversely 
correlated to the depressive-like behavior (Serchov et al., 
2015a). In addition, non-pharmacological treatments of 
depression, like ECT and transcranial magnetic stimula-
tion, a less invasive non-pharmacological antidepressant 
treatment, alternative to ECT, also upregulate Homer1a 
expression levels in the cortex (Sakagami et  al., 2005; 
Conti et al., 2007; Sun et al., 2011). Indeed, Homer1a was 
proposed to be instrumental for the therapeutic effect of 
ECT in depression (Sakagami et  al., 2005; Kato, 2009). 
Therefore, we proposed that the induction of Homer1a is 
a final common pathway mediating the antidepressant 
effects of different antidepressant treatments (Figure 1) 
(Serchov et  al., 2015a). Taken together these data point 
towards a general importance of Homer1a for antidepres-
sant therapy. However, the upstream signaling pathways 
that regulate or induce Homer1a expression are still not 
well investigated.
Adenosine A1 receptor (A1R) 
signaling to Homer1a in anti­
depressant therapy
Several non-pharmacological treatments of depression 











Figure 1: Homer1a induction mediates the antidepressant effects of 
several antidepressant treatments.
The antidepressant effects of the chronic treatment with classical 
antidepressants, such as imipramine or fluoxetine, non-pharmaco-
logical treatments, like SD and ECT, as well as single dose of keta-
mine are all accompanied and strictly dependent on the increased 
expression of Homer1a in the mPFC.
(van Calker and Biber, 2005; Burnstock et al., 2011; Sadek 
et al., 2011). Adenosine is a neuromodulator in the central 
nervous system exhibiting anticonvulsive, neuroprotective 
and sleep regulating properties (Fredholm et  al., 2005). 
Adenosine’s actions are mediated by four receptor sub-
types, A1, A2A, A2B and A3 (Fredholm et al., 2001). It is known 
that SD evokes an increased release of adenosine in the 
brain and up-regulation of adenosine A1 receptors (A1R) 
in rodents and humans (Basheer et al., 2007;  Elmenhorst 
et al., 2007, 2009). Two other non-pharmacological inter-
ventions for depression ECT and deep brain stimulation 
are associated with an increased release of adenosine and 
stimulation of A1R (van Calker and Biber, 2005; Bekar et al., 
2008; Hamani et al., 2010; Sadek et al., 2011). Furthermore, 
direct experimental data indicate that adenosine agonists 
have antidepressant activity (Hines et al., 2013). Recently, 
we demonstrated that conditional doxycycline-regulated 
upregulation of A1R expression (Serchov et al., 2012) in the 
forebrain neurons of transgenic mice (A1 mice) leads to 
pronounced acute and chronic resilience towards depres-
sive-like behavior in various tests (Serchov et al., 2015a). 
Conversely, A1RKO mice displayed an increased depres-
sive-like behavior and were resistant to the antidepressant 
effects of SD (Serchov et al., 2015a).
Interestingly, Homer1a is up-regulated by SD and ECT, 
antidepressant therapies also associated with increased 
A1R signaling (Sakagami et  al., 2005; Conti et  al., 2007; 
Elmenhorst et  al., 2007, 2009; Sadek et  al., 2011). We 
described that Homer1a expression is increased in the 
brain of A1 mice, while A1RKO mice have low Homer1a 
levels and display no induction of Homer1a in mPFC after 
SD (Serchov et al., 2015a). In addition, agonist stimulation 
of A1R in vitro in primary neuronal cultures and in vivo in 
mice increases Homer1a expression (Serchov et al., 2015a). 
A1R are usually coupled with Gi proteins, that inhibit 
cAMP formation (Fredholm et al., 2001), but when highly 
expressed in cells (e.g. neurons or smooth muscle cells) 
A1R can also regulate phospholipase C (PLC) (Biber et al., 
1997; Rogel et al., 2006; Fenton et al., 2010; Robin et al., 
2011) and extracellular signal-regulated kinase (ERK) 
pathway (Migita et al., 2008; Kunduri et al., 2013). Indeed, 
inhibition of PLC or ERK1,2 completely abolishes the A1R 
mediated increase of Homer1a expression in primary 
neurons (Serchov et al., 2015a). In addition, in vivo appli-
cation of the A1R agonist MRS5474 induces ERK1,2 acti-
vation and Homer1a levels in the mouse cortex (Serchov 
et al., 2015a), corroborating previous reports on ERKs in 
Homer1a regulation (Sato et al. 2001; Mahan et al., 2012; 
Wang et al., 2012) and providing evidence for the impor-
tance of this signaling route in depression. Taken together 
these reports suggest that several non-pharmacological 
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treatments of depression elicit their antidepressant effects 
by activation of A1R-ERK1,2 signaling mediated induction 
of Homer1a (Figure 2).
BDNF/Ras/ERK­mediated regulation 
of Homer1a in depression
Several lines of evidence show that chronic treatment 
with classical antidepressants, like imipramine and fluox-
etine upregulate Homer1a expression (Conti et al., 2007; 
Sun et al., 2011; Serchov et al., 2015a). The fact that these 
drugs require at least 2 weeks to increase Homer1a sug-
gests for indirect mechanism of regulation (Serchov et al., 
2015a). Such a mechanism might be explained by the neu-
rotrophin hypothesis, which is one of the leading hypoth-
esis towards the neurobiological basis of depression and 
which focuses on the role of brain-derived neurotrophic 
factor (BDNF). Chronic stress, a major risk factor for devel-
opment of depressive episodes, and a subsequent rise in 
plasma corticosteroid levels, causes a decrease in BDNF 
levels in several brain regions implicated in the physi-
ology of depression (Smith et  al., 1995). Conversely, a 
stress-induced downregulation of BDNF can be reversed 
by antidepressants or ECT, consistent with a delayed 
onset of the clinical efficacy of these treatments (Nibuya 
et  al., 1995). Moreover, intraventricular BDNF infusion 
causes rapid and sustained antidepressant-like effects 
( Shirayama et al., 2002). In addition, the antidepressant 
effects of ketamine require BDNF as ketamine is not affect-
ing BDNF-deficient mice (Autry et al., 2011).
According to the neurotrophin hypothesis, chronic 
treatment with classical antidepressants activate the tran-
scriptional factor cAMP response element binding protein 
(CREB), which enhances BDNF expression (Figure  2) 
(Nibuya et al., 1996; Thome et al., 2000). One of the best 
studied BDNF-regulated signaling cascades is the ERK 
pathway (Heumann, 1994). The activation of ERK-path-
way is mediated by Ras-induced MEK1,2 activation, that 
phosphorylates ERK1,2 (Figure 2) (Katz and McCormick, 
1997). Several studies have suggested that the BDNF-Ras-
ERK pathway is implicated in the control of depressive-
like behavior. The acute blockade of the ERK-pathway by 
MEK1,2 inhibition produces depressive-like phenotype 
and inhibits the effects of BDNF and several antidepres-
sant drugs on behavior (Shirayama et  al., 2002; Duman 






























Figure 2: Signaling pathways regulating Homer1a expression.
According to the neurotrophin hypothesis, classical antidepressant medications, like selective serotonin reuptake inhibitors (SSRI) and 
selective noradrenaline reuptake inhibitors (SNRI), activate by an increase of serotonin (5HT) and noradrenaline (NE) mediated signaling the 
transcription factor CREB, which enhances BDNF expression. BDNF, in turn, induces Homer1a expression via TrkB receptor-Ras-ERK-CREB 
signaling cascade. Furthermore, several non-pharmacological treatments of depression, like SD, ECT and deep brain stimulation, lead to 
increased A1R signaling. In turn, activated adenosine A1 receptor (A1R) upregulates Homer1a levels by PLCb-IP3-Ca2+-mediated activation of 
the ERK pathway; endoplasmic reticulum (ER).
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to CREB phosphorylation (Figure 2) (Xing et al., 1996). At 
the clinical level, postmortem investigations have shown 
that untreated depressive patients have lower levels of 
CREB and phosphorylated CREB in the cortex compared to 
healthy controls. In contrast, higher concentration of CREB 
was detected in patients under antidepressant medication 
compared to untreated patients (Dowlatshani et al., 1998; 
Yamada et al., 2003). Taken together these results indicate 
that stress and depression coincide with a decreased activ-
ity of the BDNF-Ras-ERK-CREB pathway, while antidepres-
sants evoke an activation of this  signaling cascade.
Several reports demonstrate that the BDNF-ERK 
pathway plays an important role in the activity-depend-
ent regulation of Homer1a (Sato et al. 2001; Mahan et al., 
2012; Wang et al., 2012). In vitro study in primary neuronal 
cultures showed that BDNF, selectively via ERK1,2 activa-
tion, upregulates Homer1a mRNA and protein levels (Sato 
et al., 2001). Furthermore, Mahan et al. (2012) reported that 
BDNF increases Homer1a mRNA expression in an ERK-
dependent manner via epigenetic modulation of Homer1a 
transcription. BDNF stimulation strongly increases histone 
H3 acetylation or decreases H3K9 methylation around the 
Homer1 promoter, resulting in enhanced Homer1a expres-
sion (Mahan et al., 2012). Interestingly, the promoter region 
of the Homer1 gene family contains several CRE binding 
sites, suggesting CREB mediation of gene transcription 
(Mahan et  al., 2012). These data suggest that the antide-
pressant drugs induced upregulation of Homer1a might be 
mediated by the BDNF-Ras-ERK-CREB pathway (Figure 2).
A recent report showed that chronic photic stimulation 
in mice has antidepressant effects and increases Homer1a 
expression in the cortex (Sun et al., 2015). Interestingly, we 
have demonstrated light-induced regulation of the Ras sign-
aling cascade (Serchov and Heumann, 2006; Serchov et al., 
2015b). In order to study the role of Ras, we have generated 
a transgenic mouse model expressing constitutively acti-
vated Ras selectively in neurons (synRas mice) (Heumann 
et  al., 2000). As Ras appears to be the major effector of 
BDNF signaling and one of the main upstream regulators of 
the ERK pathway resulting in elevated levels of CREB phos-
phorylation (Hansen et  al., 2004), such a mouse model 
might be a suitable approach to study the role of upstream 
signaling pathways regulating Homer1a in depression.
Conclusions and future 
prospectives
As the antidepressant effects mediated by chronic treat-
ment with classical antidepressant medications, like 
imipramine and fluoxetine, as well as the very rapid actions 
of ketamine and SD are all accompanied by and strictly 
dependent on an increased expression of Homer1a specifi-
cally in the mPFC, it is concluded that Homer1a induction 
is a crucial joint mechanism mediating the antidepressant 
effects. However, how Homer1a mediates antidepressant 
effects is currently unknown. As the key scaffolding mol-
ecule at the PSD, constitutively expressed long Homers 
form a polymeric network complexes linking mGluR5 with 
NMDA receptors and various proteins involved in Ca2+ 
homeostasis (Tu et al., 1998; Feng et al., 2002; Hwang et al., 
2003; Yuan et al., 2003; Perroy et al., 2008; Bertaso et al., 
2010), which have been all implicated in the pathophysiol-
ogy and treatment of depression (Galeotti et al., 2008a,b; 
Krystal et al., 2010; Miller et al., 2014; Newell and Matosin, 
2014). The induction of Homer1a, which acts as a dominant 
negative protein and declusters long Homer complexes, 
might serve as a therapeutic method in depression to mod-
ulate activity of the target proteins. Interestingly, several 
studies have shown that in vivo and in vitro application of 
a decoy peptide, which contains the Homer binding site 
of mGluR5, specifically disrupts mGluR5/Homer interac-
tions and mimics the effects of Homer1a induction (Yang 
et  al., 2004; Mao et  al., 2005; Ronesi and Huber, 2008; 
Tronson et al., 2010). Further investigation of the effects of 
this peptide in depression might provide insights on the 
mechanism of action of Homer1a and might be adopted as 
a novel approach to treat depression.
The reports presented here indicate the ERK signal-
ing cascade to be a key mediator that links distinct anti-
depressant treatments to the transcriptional induction of 
Homer1a. On the one hand, various non-pharmacological 
treatments, which are associated with increased A1R sign-
aling, might result in ERK1,2 stimulation via PLC activa-
tion, subsequent production of IP3 and intracellular Ca2+ 
release. On the other hand, several antidepressant drugs, 
both classical and novel, increase BDNF expression and 
activate the BDNF-Ras-ERK pathway. However, besides 
the ERK-dependent epigenetic modulation of Homer1a 
transcription, the precise mechanism of ERK-mediated 
regulation of Homer1a is not clear. Thus, further char-
acterization of the signaling mechanisms stimulating 
Homer1a expression might provide novel therapeutic 
targets for antidepressant drug development.
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